The National Drug Authority (NDA) is an autonomous body which was established by the National Drug Policy and Authority Act Cap 206, Laws of Uganda (2000 Edition) to regulate Human and Veterinary Medicines and other healthcare products. NDA’s mandate is to ensure quality, safety and efficacy of human and veterinary medicines and other healthcare products through the regulation and control of their production, importation, distribution and use.
NDA received a three-year grant titled “Consortium for Developing Regulatory Capacity for Clinical Trials Using Gene Therapy Products and Strengthening Pharmacovigilance in The Conduct of Clinical Trials in Uganda” (CAPACITY 2023), which will run up to 2027. The CAPACITY 2023 grant (reference: 101145599) is a project that was awarded under the Global Health European and Developing Countries Clinical Trials Partnership (EDCTP3) Joint Undertaking and by European Union through the Horizon Europe Program (HORIZON-JU-GH-EDCTP3-2023 .01 05).
Therefore, the Authority is looking for competent people with required skills, attitude and qualifications to fill the position of Regulatory Officer – Safety to support the CAPACITY 2023 Project.
The external advertisement runs from 11th to 22nd April at 5:00 PM.
Please take note of the eligibility requirements before submission: